Exchanges
BSE, NSE
Industry
Packaging
Issue
Book building

Sah Polymers IPO

₹89.25

+37.31% on listing

Listing-day close · NSE · 12 Jan 2023 · issue price ₹65

Sah Polymers’ ₹66.30 crore IPO was priced at ₹65 a share. It listed on the NSE on 12 Jan 2023 and closed its first day at ₹89.25, up 37.31% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Refunds
  5. Shares in demat
  6. Listing

Issue details

Issue size
₹66.30 Cr
Fresh issue
₹66.30 Cr
Offer for sale
—
Lot size
230 shares
Minimum investment
₹14,950
Face value
₹10
Registrar
MUFG Intime India

Subscription

Sah Polymers IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—9.92×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue)
₹168 Cr
ROE
16.42%
ROCE
14.00%
EBITDA margin
9.61%
PAT margin
5.43%
Promoter holding
100.00% → 60.46%

Financials as of 31 Mar 2022, from the offer documents.

Listing

Listing date
12 Jan 2023
Issue price
₹65
Open
₹85.00
High
₹89.25
Low
₹85.00
Close
₹89.25

Listing day on the NSE. The close was +37.31% on the issue price.

SAH share price today

FAQs

When did the Sah Polymers IPO open and close?

It opened on 30 Dec 2022 and closed on 4 Jan 2023.

What was the Sah Polymers IPO price?

The price band was ₹61–65 a share. The final issue price was ₹65.

What is the lot size and minimum investment?

One lot is 230 shares, ₹14,950 at ₹65 a share. Retail investors apply in whole lots.

How much did Sah Polymers raise?

₹66.30 crore: ₹66.30 crore of new shares.

How many times was the Sah Polymers IPO subscribed?

9.92 times overall.

How did Sah Polymers list?

It listed on the NSE on 12 Jan 2023 at ₹85.00 and closed the day at ₹89.25, up 37.31% on the ₹65 issue price.

Who is the registrar of the Sah Polymers IPO?

MUFG Intime India handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app